General
Preferred name
ACITAZANOLAST
Synonyms
MTCC ()
WP-871 ()
Acitazanolast hydrate ()
P&D ID
PD013972
CAS
114607-46-4
Tags
available
drug
Drug Status
approved
investigational
Max Phase
2.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Acitazanolast is an orally active antiallergic agent, can inhibit histamine release. Acitazanolast can be used in study of type I anaphylaxis (immediate) caused by IgE antibodies[1].
PRICE 29
DESCRIPTION Acitazanolast (WP-871) is an anti-allergic drug candidate. (TargetMol Bioactive Compound Library)
Compound Sets
10
AdooQ Bioactive Compound Library
A10034
ChEMBL Drugs
CHEMBL2104654
Drug Repurposing Hub
DrugCentral
77
DrugCentral Approved Drugs
77
DrugMatrix
MedChem Express Bioactive Compound Library
HY-13218
NPC Screening Collection
ReFrame library
TargetMol Bioactive Compound Library
T7812
External IDs
22
Properties
(calculated by RDKit )
Molecular Weight
233.05
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
3
Rotatable Bonds
2
Ring Count
2
Aromatic Ring Count
2
cLogP
-0.11
TPSA
120.86
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.62
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Indication
allergic rhinitis
MOA
mediator release inhibitor
Target
Histamine Receptor
Pathway
GPCR/G protein
Immunology/Inflammation
Neuronal Signaling
Source data